Press Resease

Pharmaceutical Unit Dose Packaging Market - Global Industry Analysis

Pharmaceutical Unit Dose Packaging Market By Material (Paper Pharmaceutical & Paperboard Pharmaceutical Unit Dose Packaging, Glass Pharmaceutical Unit Dose Packaging, Aluminum Pharmaceutical Unit Dose Packaging and Plastic & Polymers Pharmaceutical Unit Dose Packaging ), By Product (Prefilled Syringes Cartridges, Vials Pharmaceutical Unit Dose Packaging, Ampoules Pharmaceutical Unit Dose Packaging and Blisters Pharmaceutical Unit Dose Packaging), By End-Users (Orals, Respiratory Therapy, Wound Care, Biologics, Injectable, and Ophthalmic): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 18-Jun-2021 Category: Pharmaceutical Report Format : PDF Pages: 160 Report Code: ZMR-6233 Status : Published

The global Pharmaceutical Unit Dose Packaging market accounted for USD 4,448.7 Million in 2020 and is expected to reach USD 9,568.3 Million by 2028, growing at a CAGR of 10.6% from 2021 to 2028.

Description

Market Overview

The global Pharmaceutical Unit Dose Packaging market accounted for USD 4,448.7 Million in 2020 and is expected to reach USD 9,568.3 Million by 2028, growing at a CAGR of 10.6% from 2021 to 2028.

A technique of single-dose medicine distribution in non-reusable and barcoded containers is known as unit dose packaging, also known as regulatory packaging or compliance packaging. It stores a specified amount of medication in single-use containers to ensure that the patient receives the correct dose of medication when needed. It is generally used in clinics and hospitals for both solid and liquid medications. Single-dose packaging was established because of continuous packaging industry innovation to provide patients with safe and effective medication dispensing. This type of packaging was thought to be the safest because there was no risk of the prescription being refilled, and it also reduced the number of misdoes. These benefits, combined with changing lifestyles and the growing dominance of modern style culture, resulted in a broader range of uses for this product. Furthermore, the convenience and mobility benefits associated with this type of packaging are driving demand for single dosage packing.

COVID-19 Impact Analysis

During the COVID-19 epidemic, multi-dose packaging must ensure fewer ‘touchpoints' for the processing of a patient's prescriptions while preventing the confusion that comes with self-medicating. With the global roll-out of COVID-19 treatment programmes, in addition to the usual illnesses’ precautions and treatments, the need for pharmaceutical unit dose packaging is predicted to skyrocket. The demand for pharmaceuticals and medical items has increased over the COVID-19 era, resulting in an increase in blister packaging demand. As the number of COVID patients grows, new hospitals and COVID-19 centers are springing up all around the world, increasing the demand for medical treatments. By avoiding the risk of handling and pouring out liquid doses from the same bottle, unit dosage packaging benefits current and post-Covid healthcare delivery procedures. Furthermore, the increased need for the Covid-19 vaccine, as well as the government's high number of immunization programmes, has resulted in a surge in demand for unit dose packaging in vials.

Growth Factors

The major growth factors of Pharmaceutical Unit Dose Packaging Market are: Growing demand for blister packaging, Consumer preference for blister packaging, which is unit-dose packaging, has gradually shifted away from traditional bottles for pharmaceutical items. In the healthcare business, blister packs are used to package pharmaceuticals and medical devices. They are also used in a variety of consumer items, industrial items, and food-related applications. Blister packaging also uses fewer resources for packing, takes up less retail shelf space, and has a great hang-hook display. As a result, blister packs are less expensive than alternative packaging styles such as hard bottles, making them cost-effective.

In the healthcare industry, there are an increasing number of regulatory regulations to maintain GMP compliance, Regulatory bodies such as the Food and Drug Administration (US), the European Medicines Agency, and the Pharmaceuticals and Medical Devices Agency (Japan) monitor manufacturers' compliance with Current Good Manufacturing Practice (CGMP) rules to assure the quality of pharmaceuticals and medical devices. The minimal criteria for the procedures, facilities, and controls utilized in the manufacture, processing, and packing of pharmaceuticals and medical devices are outlined in CGMP rules. The restrictions in place ensure that products are safe to use and contain the ingredients and strength that they promise.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

End-Users Segment Analysis

Based on End Users Pharmaceutical Unit Dose Packaging Market is segmented into Orals, Respiratory Therapy, Wound Care, Biologics, Injectable, and Ophthalmic. During the predicted period, pharmaceutical and biotechnology companies are predicted to increase the most. In the overall pharmaceutical packaging market, the oral medication delivery route is the largest segment. The rising incidence of chronic diseases, improved patient compliance, reformulation, and repositioning of medications employing sophisticated oral delivery technologies are all factors contributing to the big market size. Large pharmaceutical companies have made significant expenditures to improve their in-house expertise in the development of oral drug delivery systems. The market has also grown due to rising demand for self-administration and home healthcare equipment, as well as the growing use of inhalers and transdermal patches for chronic conditions such as migraine, diabetes, cancer pain, and asthma.

Material Segment Analysis

Based on material, Pharmaceutical Unit Dose Packaging Market is segmented into Paper Pharmaceutical & Paperboard Pharmaceutical Unit Dose Packaging, Glass Pharmaceutical Unit Dose Packaging, Aluminum Pharmaceutical Unit Dose Packaging and Plastic & Polymers Pharmaceutical Unit Dose Packaging. Plastics and polymers such as polyvinyl chloride, polypropylene, polyethylene terephthalate, polyethylene, and polystyrene, among others, are commonly used to make pharmaceutical packaging. During the projected period, the polypropylene material is expected to expand at the fastest rate. Polypropylene is a cost-effective polymer that is used extensively in the packaging sector. Polypropylene also has a unique mixture of physical, mechanical, thermal, and electrical properties. Furthermore, it is resistant to organic solvents, degreasing chemicals, and electrolytic attack. The glass material segment reported for a revenue share of 20% percent in 2020. Glass is an inorganic material that is primarily made up of silica. Glass is used for manufacturing containers that are used for packing pharmaceutical products including parenteral, and non-parenteral preparations as well as pharmaceutical powders, among others.

Regional Segment Analysis

With a sales share of 39% in 2020, North America dominated the global market. The presence of large pharmaceutical markets such as the United States, Canada, and Mexico characterizes the region. The United States has the world's largest pharmaceutical market. The industry has been fueled by the country's extensive healthcare system, high per capita income, and significant investments in drug discovery. Furthermore, the presence of large corporations such as Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., Bristol-Myers Squibb Company, and AbbVie Inc. is expected to boost regional growth.

The Asia Pacific region is projected to grow at a CAGR of 10.3% over the forecast period. Over the forecast period, Asia Pacific is expected to grow at the fastest rate. The most important regional markets are China, India, Japan, and South Korea. In the future years, steady economic expansion combined with strong population growth in the region is predicted to stimulate product demand. Furthermore, increased government restrictions for drug safety are projected to fuel regional expansion.

Key Market Players & Competitive Landscape

Some of key players in Pharmaceutical Unit Dose Packaging Market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bristol-Myers Squibb Company, AbbVie Inc., UDG Healthcare plc, Comar LLC, Berry Global, Inc., Gerresheimer AG, Amcor plc, among others.

The global Pharmaceutical Unit Dose Packaging market is segmented as follows:

By Material

  • Paper Pharmaceutical & Paperboard Pharmaceutical Unit Dose Packaging
  • Glass Pharmaceutical Unit Dose Packaging
  • Aluminum Pharmaceutical Unit Dose Packaging
  • Plastic & Polymers Pharmaceutical Unit Dose Packaging

By Product

  • Prefilled Syringes Cartridges
  • Vials Pharmaceutical Unit Dose Packaging
  • Ampoules Pharmaceutical Unit Dose Packaging
  • Blisters Pharmaceutical Unit Dose Packaging

By End-Users

  • Orals
  • Respiratory Therapy
  • Wound Care
  • Biologics
  • Injectable
  • Ophthalmic

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Chapter No. 1. Introduction

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. USP & Key Offerings
  • 1.2. Key Benefits for Stakehulders
  • 1.3. Target Audience
  • 1.4. Report Scope

Chapter No. 2. Executive Summary

  • 2.1. Key Findings
    • 2.1.1. Top Investment Pockets
      • 2.1.1.1. Market Attractiveness Analysis, By Material
      • 2.1.1.2. Market Attractiveness Analysis, By Product
      • 2.1.1.3. Market Attractiveness Analysis, By End-Users
      • 2.1.1.4. Market Attractiveness Analysis, By Region
  • 2.2. Market Snapshot
  • 2.3. Global Pharmaceutical Unit Dose Packaging Market, 2016 – 2028 (USD Million)
  • 2.4. Insights from Primary Respondents

Chapter No. 3. COVID 19 Impact Analysis

  • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. The Middle-East and Africa
  • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
  • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
  • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
  • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
    • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
  • 3.6. Short Term Dynamics
  • 3.7. Long Term Dynamics

Chapter No. 4. Pharmaceutical Unit Dose Packaging Market – Material Segment Analysis

  • 4.1. Overview
    • 4.1.1. Market Revenue Share, By Material, 2020 & 2028
  • 4.2. Paper Pharmaceutical & Paperboard Pharmaceutical Unit Dose Packaging
    • 4.2.1. Market Size and Forecast, By Region (USD Million)
    • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.3. Glass Pharmaceutical Unit Dose Packaging
    • 4.3.1. Market Size and Forecast, By Region (USD Million)
    • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.4. Aluminum Pharmaceutical Unit Dose Packaging
    • 4.4.1. Market Size and Forecast, By Region (USD Million)
    • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.5. Plastic & Pulymers Pharmaceutical Unit Dose Packaging
    • 4.5.1. Market Size and Forecast, By Region (USD Million)
    • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.5.3. Key Market Trends, Growth Factors, & Opportunities

Chapter No. 5. Pharmaceutical Unit Dose Packaging Market – Product Segment Analysis

  • 5.1. Overview
    • 5.1.1. Market Revenue Share, By Product, 2020 & 2028
  • 5.2. Prefilled Syringes Cartridges
    • 5.2.1. Market Size and Forecast, By Region (USD Million)
    • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.3. Vials Pharmaceutical Unit Dose Packaging
    • 5.3.1. Market Size and Forecast, By Region (USD Million)
    • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.4. Ampoules Pharmaceutical Unit Dose Packaging
    • 5.4.1. Market Size and Forecast, By Region (USD Million)
    • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.5. Blisters Pharmaceutical Unit Dose Packaging
    • 5.5.1. Market Size and Forecast, By Region (USD Million)
    • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.5.3. Key Market Trends, Growth Factors, & Opportunities

Chapter No. 6. Pharmaceutical Unit Dose Packaging Market – End-Users Segment Analysis

  • 6.1. Overview
    • 6.1.1. Market Revenue Share, By End-Users, 2020 & 2028
  • 6.2. Orals
    • 6.2.1. Market Size and Forecast, By Region (USD Million)
    • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.3. Respiratory Therapy
    • 6.3.1. Market Size and Forecast, By Region (USD Million)
    • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.4. Wound Care
    • 6.4.1. Market Size and Forecast, By Region (USD Million)
    • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.5. Biulogics
    • 6.5.1. Market Size and Forecast, By Region (USD Million)
    • 6.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.5.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.6. Injectable
    • 6.6.1. Market Size and Forecast, By Region (USD Million)
    • 6.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.6.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.7. Ophthalmic
    • 6.7.1. Market Size and Forecast, By Region (USD Million)
    • 6.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.7.3. Key Market Trends, Growth Factors, & Opportunities

Chapter No. 7. Pharmaceutical Unit Dose Packaging Market – Regional Analysis

  • 7.1. Overview
    • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
    • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 7.2.2. North America Market Revenue, By Material, 2016 – 2028
    • 7.2.3. North America Market Revenue, By Product, 2016 – 2028
    • 7.2.4. North America Market Revenue, By End-Users, 2016 – 2028
    • 7.2.5. U.S.
      • 7.2.5.1. U.S. Market Revenue, By Material, 2016 – 2028
      • 7.2.5.2. U.S. Market Revenue, By Product, 2016 – 2028
      • 7.2.5.3. U.S. Market Revenue, By End-Users, 2016 – 2028
    • 7.2.6. Canada
      • 7.2.6.1. Canada Market Revenue, By Material, 2016 – 2028
      • 7.2.6.2. Canada Market Revenue, By Product, 2016 – 2028
      • 7.2.6.3. Canada Market Revenue, By End-Users, 2016 – 2028
    • 7.2.7. Mexico
      • 7.2.7.1. Mexico Market Revenue, By Material, 2016 – 2028
      • 7.2.7.2. Mexico Market Revenue, By Product, 2016 – 2028
      • 7.2.7.3. Mexico Market Revenue, By End-Users, 2016 – 2028
  • 7.3. Europe
    • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 7.3.2. Europe Market Revenue, By Material, 2016 – 2028
    • 7.3.3. Europe Market Revenue, By Product, 2016 – 2028
    • 7.3.4. Europe Market Revenue, By End-Users, 2016 – 2028
    • 7.3.5. Germany
      • 7.3.5.1. Germany Market Revenue, By Material, 2016 – 2028
      • 7.3.5.2. Germany Market Revenue, By Product, 2016 – 2028
      • 7.3.5.3. Germany Market Revenue, By End-Users, 2016 – 2028
    • 7.3.6. France
      • 7.3.6.1. France Market Revenue, By Material, 2016 – 2028
      • 7.3.6.2. France Market Revenue, By Product, 2016 – 2028
      • 7.3.6.3. France Market Revenue, By End-Users, 2016 – 2028
    • 7.3.7. U.K.
      • 7.3.7.1. U.K. Market Revenue, By Material, 2016 – 2028
      • 7.3.7.2. U.K. Market Revenue, By Product, 2016 – 2028
      • 7.3.7.3. U.K. Market Revenue, By End-Users, 2016 – 2028
    • 7.3.8. Italy
      • 7.3.8.1. Italy Market Revenue, By Material, 2016 – 2028
      • 7.3.8.2. Italy Market Revenue, By Product, 2016 – 2028
      • 7.3.8.3. Italy Market Revenue, By End-Users, 2016 – 2028
    • 7.3.9. Spain
      • 7.3.9.1. Spain Market Revenue, By Material, 2016 – 2028
      • 7.3.9.2. Spain Market Revenue, By Product, 2016 – 2028
      • 7.3.9.3. Spain Market Revenue, By End-Users, 2016 – 2028
    • 7.3.10. Rest of Europe
      • 7.3.10.1. Rest of Europe Market Revenue, By Material, 2016 – 2028
      • 7.3.10.2. Rest of Europe Market Revenue, By Product, 2016 – 2028
      • 7.3.10.3. Rest of Europe Market Revenue, By End-Users, 2016 – 2028
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 7.4.2. Asia Pacific Market Revenue, By Material, 2016 – 2028
    • 7.4.3. Asia Pacific Market Revenue, By Product, 2016 – 2028
    • 7.4.4. Asia Pacific Market Revenue, By End-Users, 2016 – 2028
    • 7.4.5. China
      • 7.4.5.1. China Market Revenue, By Material, 2016 – 2028
      • 7.4.5.2. China Market Revenue, By Product, 2016 – 2028
      • 7.4.5.3. China Market Revenue, By End-Users, 2016 – 2028
    • 7.4.6. Japan
      • 7.4.6.1. Japan Market Revenue, By Material, 2016 – 2028
      • 7.4.6.2. Japan Market Revenue, By Product, 2016 – 2028
      • 7.4.6.3. Japan Market Revenue, By End-Users, 2016 – 2028
    • 7.4.7. India
      • 7.4.7.1. India Market Revenue, By Material, 2016 – 2028
      • 7.4.7.2. India Market Revenue, By Product, 2016 – 2028
      • 7.4.7.3. India Market Revenue, By End-Users, 2016 – 2028
    • 7.4.8. South Korea
      • 7.4.8.1. South Korea Market Revenue, By Material, 2016 – 2028
      • 7.4.8.2. South Korea Market Revenue, By Product, 2016 – 2028
      • 7.4.8.3. South Korea Market Revenue, By End-Users, 2016 – 2028
    • 7.4.9. South-East Asia
      • 7.4.9.1. South-East Asia Market Revenue, By Material, 2016 – 2028
      • 7.4.9.2. South-East Asia Market Revenue, By Product, 2016 – 2028
      • 7.4.9.3. South-East Asia Market Revenue, By End-Users, 2016 – 2028
    • 7.4.10. Rest of Asia Pacific
      • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Material, 2016 – 2028
      • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 7.4.10.3. Rest of Asia Pacific Market Revenue, By End-Users, 2016 – 2028
  • 7.5. Latin America
    • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 7.5.2. Latin America Market Revenue, By Material, 2016 – 2028
    • 7.5.3. Latin America Market Revenue, By Product, 2016 – 2028
    • 7.5.4. Latin America Market Revenue, By End-Users, 2016 – 2028
    • 7.5.5. Brazil
      • 7.5.5.1. Brazil Market Revenue, By Material, 2016 – 2028
      • 7.5.5.2. Brazil Market Revenue, By Product, 2016 – 2028
      • 7.5.5.3. Brazil Market Revenue, By End-Users, 2016 – 2028
    • 7.5.6. Argentina
      • 7.5.6.1. Argentina Market Revenue, By Material, 2016 – 2028
      • 7.5.6.2. Argentina Market Revenue, By Product, 2016 – 2028
      • 7.5.6.3. Argentina Market Revenue, By End-Users, 2016 – 2028
    • 7.5.7. Rest of Latin America
      • 7.5.7.1. Rest of Latin America Market Revenue, By Material, 2016 – 2028
      • 7.5.7.2. Rest of Latin America Market Revenue, By Product, 2016 – 2028
      • 7.5.7.3. Rest of Latin America Market Revenue, By End-Users, 2016 – 2028
  • 7.6. The Middle-East and Africa
    • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 7.6.2. The Middle-East and Africa Market Revenue, By Material, 2016 – 2028
    • 7.6.3. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
    • 7.6.4. The Middle-East and Africa Market Revenue, By End-Users, 2016 – 2028
    • 7.6.5. GCC Countries
      • 7.6.5.1. GCC Countries Market Revenue, By Material, 2016 – 2028
      • 7.6.5.2. GCC Countries Market Revenue, By Product, 2016 – 2028
      • 7.6.5.3. GCC Countries Market Revenue, By End-Users, 2016 – 2028
    • 7.6.6. South Africa
      • 7.6.6.1. South Africa Market Revenue, By Material, 2016 – 2028
      • 7.6.6.2. South Africa Market Revenue, By Product, 2016 – 2028
      • 7.6.6.3. South Africa Market Revenue, By End-Users, 2016 – 2028
    • 7.6.7. Rest of Middle-East Africa
      • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Material, 2016 – 2028
      • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
      • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By End-Users, 2016 – 2028

Chapter No. 8. Pharmaceutical Unit Dose Packaging Market – Industry Analysis

  • 8.1. Introduction
  • 8.2. Market Drivers
    • 8.2.1. Driving Factor 1 Analysis
    • 8.2.2. Driving Factor 2 Analysis
  • 8.3. Market Restraints
    • 8.3.1. Restraining Factor Analysis
  • 8.4. Market Opportunities
    • 8.4.1. Market Opportunity Analysis
  • 8.5. Porter’s Five Forces Analysis
  • 8.6. PEST Analysis
  • 8.7. Regulatory Landscape
  • 8.8. Technology Landscape
  • 8.9. Regional Market Trends
    • 8.9.1. North America
    • 8.9.2. Europe
    • 8.9.3. Asia Pacific
    • 8.9.4. Latin America
    • 8.9.5. The Middle-East and Africa
  • 8.10. Pricing Analysis
  • 8.11. Value Chain Analysis
  • 8.12. Downstream Buyers
  • 8.13. Distributors/Traders List

Chapter No. 9. Competitive Landscape

  • 9.1. Company Market Share Analysis – 2019
    • 9.1.1. Global Pharmaceutical Unit Dose Packaging Market: Company Market Share, 2019
    • 9.1.2. Global Pharmaceutical Unit Dose Packaging Market, Company Market Revenue, 2016 – 2019 (USD Million)
    • 9.1.3. Global Pharmaceutical Unit Dose Packaging Market, Company Y-o-Y Growth, 2017 – 2019 (%)
    • 9.1.4. Global Pharmaceutical Unit Dose Packaging Market: Radar Determinant Chart, 2019
  • 9.2. Strategic Developments
    • 9.2.1. Acquisitions & Mergers
    • 9.2.2. New Product Launch
    • 9.2.3. Regional Expansion
  • 9.3. Company Strategic Developments – Heat Map Analysis

Chapter No. 10. Company Profiles

  • 10.1. Pfizer Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Product Portfolio
    • 10.1.4. Financial Overview
    • 10.1.5. Operating Business Segments
    • 10.1.6. Business Performance
    • 10.1.7. Recent Developments
  • 10.2. Johnson & Johnson
  • 10.3. Merck & Co. Inc.
  • 10.4. Bristul-Myers Squibb Company
  • 10.5. AbbVie Inc.
  • 10.6. UDG Healthcare plc
  • 10.7. Comar LLC
  • 10.8. Berry Global Inc.
  • 10.9. Gerresheimer AG
  • 10.10. Amcor plc

Chapter No. 11. Marketing Strategy Analysis

  • 11.1. Marketing Channel
  • 11.2. Direct Marketing
  • 11.3. Indirect Marketing
  • 11.4. Marketing Channel Development Trends
  • 11.5. Economic/Pulitical Environmental Change

Chapter No. 12. Research Methodology

  • 12.1. Research Methodology
  • 12.2. Phase I - Secondary Research
  • 12.3. Phase II - Data Modeling
    • 12.3.1. Company Share Analysis Model
    • 12.3.2. Revenue Based Modeling
  • 12.4. Phase III - Primary Research
  • 12.5. Research Limitations
    • 12.5.1. Assumptions

Methodology


Frequently Asked Questions

The global Pharmaceutical Unit Dose Packaging market was valued at USD 4,448.7 Million in 2020.
The global Pharmaceutical Unit Dose Packaging market is expected to reach USD 9,568.3 Million by 2028, growing at a CAGR of 10.6% between 2021 to 2028.
Some of the key factors driving the global Pharmaceutical Unit Dose Packaging market growth are Blister packing is becoming increasingly popular and In the healthcare industry, there are an increasing number of regulatory regulations to maintain GMP compliance.

The Asia Pacific region is projected to grow at a CAGR of 10.3% over the forecast period. Over the forecast period, Asia Pacific is expected to grow at the fastest rate. North America dominated the world market in 2020, with a sales share of 39%. The region is defined by the presence of large pharmaceutical markets such as the United States, Canada, and Mexico.

Some of the major companies operating in the Pharmaceutical Unit Dose Packaging market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bristol-Myers Squibb Company, AbbVie Inc., UDG Healthcare plc, Comar LLC, Berry Global, Inc., Gerresheimer AG, Amcor plc, among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social